Atlantic Equities Upgrades Abbott Labs (ABT) to Overweight
Tweet
Share
E-mail
Get Alerts ABT Hot Sheet
Price: $105.27 -0.59%
Rating Summary:
18 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 17
Rating Summary:
18 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 17
Join SI Premium – FREE
Atlantic Equities analyst James Mainwaring upgraded Abbott Labs (NYSE: ABT) from Neutral to Overweight with a price target of $144.00.
For an analyst ratings summary and ratings history on Abbott Labs click here. For more ratings news on Abbott Labs click here.
Shares of Abbott Labs closed at $128.13 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
- KeyBanc Upgrades Zscaler (ZS) to Overweight
- Abbott Laboratories (ABT) narrows 2024 earnings guidance, shares slip
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
